Suicide risk in placebo-controlled trials of treatment for acute manic episode and prevention of manic-depressive episode

American Journal of Psychiatry

Volumn 162, Issue 4, 2005, Pages 799-802

  Storosum, Jitschak G ^a   Wohlfarth, Tamar ^b   Gispen De Wied, Christine C ^b   Linszen, Don H ^b   Gersons, Berthold P R ^b   Van Zwieten, Barbara J ^b   Van Den Brink, Wim ^b  

^a Med Eval Bd of the Netherlands   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; LITHIUM; PLACEBO; VALPROATE SEMISODIUM;

BIPOLAR DISORDER; CLINICAL TRIAL; ETHICS; HUMAN; MANIA; NETHERLANDS; PRIORITY JOURNAL; REVIEW; SUICIDE; SUICIDE ATTEMPT; TREATMENT OUTCOME;

ACUTE DISEASE; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CLINICAL TRIALS DATA MONITORING COMMITTEES; DOUBLE-BLIND METHOD; ETHICS, RESEARCH; HALOPERIDOL; HUMANS; LITHIUM; NETHERLANDS; PLACEBOS; RANDOMIZED CONTROLLED TRIALS; RISK FACTORS; SUICIDE; SUICIDE, ATTEMPTED;

EID: 16844381195     PISSN: 0002953X     EISSN: None     Source Type: Journal    
DOI: 10.1176/appi.ajp.162.4.799     Document Type: Review

References (19)

1. Rothman KJ, Michels KB: The continuing unethical use of placebo controls. N Engl J Med 1994; 331:394-398
2. Rothman KJ: Declaration of Helsinki should be strengthened. BMJ 2000; 321:442-445
3. European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products: Note for Guidance on Clinical Investigation of Medicinal Products for the Treatment and Prevention of Bipolar Disorder. London, EMEA, April 2001. http://www.emea.eu.int/pdfs/human/ewp/ 056798en.pdf
4. Harris EC, Barraclough B: Suicide as an outcome for mental disorders: a meta-analysis. Br J Psychiatry 1997; 170:205-228
5. Tondo L, Isacsson G, Baldessarini RJ: Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs 2003; 17:491-511
6. Baldessarini RJ, Tondo L: Suicide risk and treatments for patients with bipolar disorder (editorial). JAMA 2003; 290:1517-1519; correction, 2004; 291:186
7. Baldessarini RJ, Tondo L, Hennen J: Lithium treatment and suicide risk in major affective disorders: update and new findings. J Clin Psychiatry 2003; 64(suppl 5):44-52
8. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D: Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA 2003; 290:1467-1473
9. Tondo L, Hennen J, Baldessarini RJ: Lower suicide risk with long-term lithium treatment in major affective illness: a meta-analysis. Acta Psychiatr Scand 2001; 104:163-172
10. Baldessarini RJ, Tondo L, Hennen J: Treating the suicidal patient with bipolar disorder: reducing suicide risk with lithium. Ann NY Acad Sci 2001; 932:24-43
11. Fourth International Bipolar Conference, Session IV: Regulatory Issues in Developing Drug Treatments for Bipolar Disorder, June 14-16, 2001. http://www.hsls.pitt.edu/about/libraries/wpic/bipolar4.html
12. European Agency for the Evaluation of Medicinal Products (EMEA), Committee for Proprietary Medicinal Products: Note for Guidance on Good Clinical Practice. London, EMEA, Sept 1997. http://www.emea.eu.int/pdfs/human/ich/ 013595en.pdf
13. Khan A, Warner HA, Brown WA: Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: an analysis of the Food and Drug Administration database. Arch Gen Psychiatry 2000; 57:311-317
14. Storosum JG, van Zwieten BJ, van den Brink W, Gersons BPR, Broekmans AW: Suicide risk in placebo-controlled studies of major depression. Am J Psychiatry 2001; 158:1271-1275
15. Khan A, Khan SR, Leventhal RM, Brown WA: Symptom reduction and suicide risk among patients treated with placebo in antipsychotic clinical trials: an analysis of the Food and Drug Administration database. Am J Psychiatry 2001; 158:1449-1454
16. Storosum JG, van Zwieten BJ, Wohlfarth T, de Haan L, Khan A, van den Brink W: Suicide risk in placebo vs active treatment in placebo-controlled trials for schizophrenia. Arch Gen Psychiatry 2003; 60:365-368
17. Isometsä ET, Henriksson MM, Aro HM, Lonnqvist JK: Suicide in bipolar disorder in Finland. Am J Psychiatry 1994; 151:1020-1024
18. Ahrens B, Müller-Oerlinghausen B, Schou M, Wolf T, Aida M, Grof E, Grof P, Lenz G, Simhandl C, Thau K, Vestergaard P, Wolf R, Möller HJ: Excess cardiovascular and suicide mortality of affective disorders may be reduced by lithium prophylaxis. J Affect Disord 1995; 33:67-75
19. Rihmer Z, Pestality P: Bipolar II disorder and suicidal behavior. Psychiatr Clin North Am 1999; 22:667-673